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Rapid and specific purification of Argonaute-small
RNA complexes from crude cell lysates
C. FABIÁN FLORES-JASSO, WILLIAM E. SALOMON, and PHILLIP D. ZAMORE1
Howard Hughes Medical Institute and Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School,
Worcester, Massachusetts 01605, USA
ABSTRACT
Small interfering RNAs (siRNAs) direct Argonaute proteins, the core components of the RNA-induced silencing complex (RISC), to
cleave complementary target RNAs. Here, we describe a method to purify active RISC containing a single, unique small RNA guide
sequence. We begin by capturing RISC using a complementary 2′-O-methyl oligonucleotide tethered to beads. Unlike other
methods that capture RISC but do not allow its recovery, our strategy purifies active, soluble RISC in good yield. The method
takes advantage of the finding that RISC partially paired to a target through its siRNA guide dissociates more than 300 times
faster than a fully paired siRNA in RISC. We use this strategy to purify fly Ago1- and Ago2-RISC, as well as mouse AGO2-RISC.
The method can discriminate among RISCs programmed with different guide strands, making it possible to deplete and recover
specific RISC populations. Endogenous microRNA:Argonaute complexes can also be purified from cell lysates. Our method
scales readily and takes less than a day to complete.
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INTRODUCTION
Small interfering RNAs (siRNAs) and microRNAs (miRNAs)
mediate the post-transcriptional repression of complementa-
ry target RNAs (Bartel 2009; Ghildiyal and Zamore 2009).
siRNAs typically guide the cleavage of extensively comple-
mentary RNAs (Hammond et al. 2000; Zamore et al. 2000;
Elbashir et al. 2001a,b), a phenomenon called RNA interfer-
ence (RNAi). In contrast, most animalmiRNAs target partial-
ly complementary RNAs, triggering their destruction (Baek
et al. 2008; Selbach et al. 2008; Ingolia et al. 2009; Guo et al.
2010) and, in some cases, repressing their translation into pro-
tein (Hendrickson et al. 2009; Bazzini et al. 2012). Both
siRNAs and miRNAs assemble with Argonaute proteins to
form the RNA-induced silencing complex (RISC). Assembly
of siRNA ormiRNA/miRNA∗ duplexes into RISCs is facilitat-
ed by proteins that orient the siRNA, such as the Dicer-2/
R2D2 heterodimer in insects, and by proteins thought to
allow conformational rearrangement of Argonaute, such as
HSP90 and Hsc70 chaperones (Tahbaz et al. 2001; Iki
et al. 2010; Iwasaki et al. 2010; Johnston et al. 2010; Miyoshi
et al. 2010; Olivieri et al. 2012; Preall et al. 2012; Xiol et al.
2012).
InDrosophilamelanogaster, miRNAs and siRNAs are sorted
between Argonaute1 (Ago1) and Argonaute2 (Ago2) accord-
ing to their duplex structure and the identity of their first nu-
cleotide (Forstemann et al. 2007; Tomari et al. 2007; Czech
et al. 2008; Ghildiyal et al. 2008; Okamura et al. 2008; Seitz
et al. 2011). The extensively double-stranded structure of
siRNA sends them into Ago2, while the presence of specific
mismatches within the miRNA/miRNA∗ duplex directs
miRNAs into Ago1. Inmammals, whose four Argonaute pro-
teins are more closely related to fly Ago1 than to fly Ago2
(Tolia and Joshua-Tor 2007), no sorting mechanism has
thus far been detected, and miRNAs and siRNAs assemble
into AGO1, AGO2, AGO3, and AGO4. In mice and humans,
only AGO2 can catalyze target cleavage (Liu et al. 2004;
Meister et al. 2004b).
Chemically modified, complementary oligonucleotides
that bind siRNAs and miRNAs block their activity in vitro
and in vivo (Hutvágner et al. 2004; Meister et al. 2004a;
Krutzfeldt et al. 2005; Leaman et al. 2005; Elmen et al.
2008; Lanford et al. 2010; Obad et al. 2011). The most widely
used anti-miRNA oligonucleotides use 2′-O-methyl ribose
modifications to block degradation of the oligonucleotide.
Such 2′-O-methyl anti-miRNA oligonucleotides not only in-
hibit miRNA function in cultured cell lines, cell lysates, and
Caenorhabditis elegans (Hutvágner et al. 2004; Zheng et al.
2010), but also can be used to capture Argonaute complexes
programmed with a specific small RNA sequence (Hutvágner
et al. 2004). Unfortunately, RISC captured with a fully
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complementary 2′-O-methyl oligonucleotides tethered to
beads cannot be recovered under native conditions, preclud-
ing its further study.
Despite great advances in understanding the miRNA and
siRNA pathways, the biochemical details of how Argonaute
proteins function remain incomplete. A key limitation in
the study of Argonaute protein function is the lack of meth-
ods to purify RISC complexes assembled through natural
pathways and that contain a single, unique guide sequence.
Purification of RISC using antibodies against endogenous
or epitope-tagged Argonautes allows the selection of specific
Argonaute proteins, but these contain a complex mixture of
siRNA and miRNA guides (Hutvágner and Zamore 2002;
Mourelatos et al. 2002; Liu et al. 2004; Meister et al. 2004a;
Ikeda et al. 2006; Beitzinger et al. 2007; Azuma-Mukai et al.
2008). RISC has also been purified using a guide strand
with a 3′ biotin joined to the siRNA through a UV-sensitive
linker, which was cleaved by photolysis (Martinez et al. 2002;
Martinez and Tuschl 2004; Ameres et al. 2007) and using
tethered siRNAs from which proteins were recovered with
denaturing buffers (Gerbasi et al. 2010). However, photolysis
is inefficient, and recovery by denaturation, of course, fails to
preserve RISC activity. Both approaches can only be used to
isolate experimentally programmed RISC, whereas ourmeth-
od permits purification of endogenous complexes from cell
and tissue extracts.
Recombinant eukaryotic Argonaute proteins have been
produced in bacteria, and in insect, yeast, human, and lepi-
dopteran cells (Rivas et al. 2005; MacRae et al. 2008; Ye
et al. 2011; Elkayam et al. 2012; Nakanishi et al. 2012;
Schirle and MacRae 2012). Recombinant Argonaute proteins
can be partially inactive (Rivas et al. 2005) and often contain
endogenous RNAs (Nakanishi et al. 2012; Schirle and
MacRae 2012). Furthermore, recombinant Argonaute pro-
teins must be loaded with single-stranded RNA, a pathway
not thought to exist in vivo, and lack associated proteins
that may modify Argonaute function.
Here, we describe a method to purify active Argonaute
complexes (RISCs) containing a single, unique small RNA
guide. Like previous techniques, our method begins by cap-
turing RISC using a complementary 2′-O-methyl oligonucle-
otide tethered to paramagnetic beads (the capture oligo). The
strategy takes advantage of the finding that fly Ago2-RISC
dissociates from a target RNAmore than 300 times more rap-
idly when its guide strand is partially paired than when it is
fully paired to a target (Wee et al. 2012). We can therefore
elute purified, active, soluble RISC from the capture oligo
in good yield in native conditions. We use this strategy to pu-
rifyDrosophila Ago2-RISC bearing an siRNA and Ago1-RISC
loaded with an miRNA, as well as an siRNA assembled into
mouse AGO2 in lysates from immortalized embryonic fibro-
blasts. Finally, we show that active RISC can be selectively pu-
rified from a population of RISCs containing different guide
strands. This method scales readily and takes no more than a
single day to complete.
RESULTS
miRNA-like pairing allows efficient capture
and release of RISC
We incubated an siRNAduplex inDrosophila embryo lysate to
assemble the guide strand into Ago2-RISC. We captured the
RISC containing the siRNA guide using a 31-nt 2′-O-methyl
oligonucleotide tethered via a 5′ biotin to streptavidin-para-
magnetic beads. RISC, captured on the oligo, was thenwashed
in buffer containing 2 M potassium acetate and eluted with a
competitor DNA oligonucleotide fully complementary to the
capture oligo in buffer containing 1 M potassium acetate.
Figure 1 illustrates the method. Three types of capture oligos
were tested: an oligo fully complementary to the siRNA guide;
an oligo complementary only to the seed of the siRNA (posi-
tions 2–8); and an oligo complementary to the seed and four
nucleotides in the 3′ supplementary region of the siRNA. The
amount of capture oligo used (5 µM) was greater than the
concentration of 2′-O-methyl oligonucleotide (1–2 µM)
that fully blocks target cleavage directed by this siRNA in
Drosophila embryo lysate (Supplemental Fig. S1).
To monitor the efficiency of binding and recovery of
siRNA-programmed RISC for each of the three types of cap-
ture oligos, we assayed cleavage of a 5′ 32P-radiolabeled target
RNA (Fig. 2). In parallel, we followed a 5′ 32P-radiolabeled
guide siRNA through the purification procedure (Table 1).
The fully complementary capture oligo, the capture oligo
with seed plus 3′ supplementary pairing, and the capture oligo
pairing only with the seed all effectively depleted the pro-
grammed RISC from the lysate:We detected <2% of the orig-
inal RISC cleaving activity in the supernatant of an assembly
reaction incubated with any of the capture oligos tethered to
paramagnetic beads or in the subsequent, pooled washes
(100 mM and 2 M potassium acetate). For the fully comple-
mentary capture oligo, addition of a competitor oligonucleo-
tide (the competitor) complementary to the capture oligo
capture oligo1. capture
2. wash
Assembled
RISC
p
p
3. elute competitor oligo
Purified
RISC
+
p
siRNA guide
Ago2
FIGURE 1. Strategy to purify active RISC.
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failed to release any detectable target-cleaving RISC activity
(Table 1). In contrast, a competitor efficiently released active
RISC from the capture oligo complementary to only the seed
plus the 3′ supplementary region or the seed alone. We note
that high salt (1 M potassium acetate) was essential: At lower
salt concentrations, addition of a competitor complementary
to the capture oligo failed to release any detectable target-
cleaving RISC activity (Fig. 2) or 32P-radiolabeled guide
siRNA (Table 1, cf. “low salt + competitor” to “eluate”).
The RISC eluted by this method contains competitor DNA
that is partially complementary to an RNA target fully match-
ing the siRNA guide. In practice, the contaminating compet-
itor DNA does not detectably interfere with target cleavage.
However, the competitor can be readily removed by subse-
quent ion exchange chromatography (see Materials and
Methods).
Purification of Ago1 programmed with an miRNA
In flies, canonical miRNA/miRNA∗ duplexes load Ago1 rath-
er than Ago2 (Forstemann et al. 2007; Tomari et al. 2007). To
test whether the method could be used to selectively purify
Ago1-RISC, we incubated a let-7/let-7∗ duplex with
Drosophila embryo lysate, and then purified the let-7-pro-
grammed Ago1-RISC using the capture oligo complementa-
ry to the seed plus the 3′ supplementary region. Although
Ago 1-RISC is inherently less catalytically active than Ago2
(kcat/KM for Ago2 is >60-fold greater than for Ago1) and tar-
get cleavage is unlikely to play an important role in Ago1-me-
diated mRNA repression (Forstemann et al. 2007), Ago1 can
be followed by target cleaving activity (Fig. 3A). Target cleav-
age assays of let-7-programmed Ago1-RISC detected activity
in the input and eluate samples (Fig. 3A). Quantitative mass
spectrometry (Fig. 3C) revealed that the eluate was more en-
riched for Ago1 (467-fold over background) than for Ago2
(fivefold enrichment). In contrast, RISC assembled with a
let-7 siRNA (Fig. 3B,C; Supplemental Tables S1, S2) con-
tained mainly Ago2 (356-fold enrichment over background)
rather than Ago1 (1.6-fold enrichment). Importantly, we
used the same capture oligo to purify each Argonaute
complex, changing only the let-7 duplex used to assemble
RISC. Flies do not produce let-7 during embryogenesis
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FIGURE 2. Active RISC can be eluted from a capture oligo partially complementary to the small RNA guide. let-7-programmed Drosophila Ago2-
RISC, assembled in Drosophila embryo lysate, was incubated with a capture oligo fully complementary to let-7, to the let-7 seed plus 3′ supplementary
region, or only to the let-7 seed sequence. The RISC assembly reaction (Input), the supernatant after capture (Sup), the washes (five with 100 mM and
five with 2 M potassium acetate, pooled and concentrated to the volume of the original RISC assembly reaction, 100 µL; Wash), and the eluate from
the capture oligos were incubated with 100 nM target RNA for 5 min at 25°C to detect Ago2-RISC activity. (Ø) No incubation.
TABLE 1. Yield of fly Ago2-RISC eluted from the capture oligo
Capture oligo complementarity
Active
RISC
assembled
siRNA in
supernatant
Washes
Eluate (high
salt +
competitor) YieldLow salt
Low salt +
competitor High salt
None 12 ± 1 16 ± 1 0.15 ± 0.01 0.10 ± 0.01 0.83 ± 0.06 0.13 + 0.01 1.1%
Complete complementarity to guide strand 12 ± 1 10 ± 1 0.43 ± 0.01 0.092 ± 0.008 0.10 ± 0.01 0.29 ± 0.03 2.4%
Guide strand seed plus 3′ supplementary 12 ± 1 7.4 ± 0.4 0.10 ± 0.02 0.12 ± 0.02 0.10 ± 0.02 9.4 ± 0.1 78%
Guide strand seed only 12 ± 1 8.1 ± 0.4 0.11 ± 0.01 0.11 ± 0.01 0.097 ± 0.009 9.6 ± 0.6 80%
Passenger strand seed plus 3′ supplementary 12 ± 1 21 ± 1 0.22 ± 0.05 0.12 ± 0.07 0.082 ± 0.008 0.082 ± 0.008 0.68%
RISC was assembled in Drosophila embryo lysate using 25 nM siRNA duplex. For the supernatant and washes, the amount of 5′ 32P-radiola-
beled siRNA (pmol) was measured as a surrogate for RISC. Active RISC assembled and eluted was measured as described in the Materials and
Methods. Data are mean ± SD, n = 3.
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(Pasquinelli et al. 2000), thus all let-7 RISC activity reflects
Argonaute programmed in the lysate by the let-7 siRNA or
miRNA/miRNA∗ duplex.
Purification of mouse AGO2-RISC
Our method also effectively purifies mammalian AGO2-
RISC.We prepared cytosolic S100 extract from immortalized,
Ago2−/− mouse embryonic fibroblasts (MEFs) (O’Carroll
et al. 2007; Broderick et al. 2011) that stably express ∼30-
fold more Ago2 mRNA than wild-type MEFs, and incubated
the S100 with a let-7 siRNA duplex to program RISC. We
used the same capture oligo and protocol as for fly RISC
and then tested the eluate for target cleaving activity
(Fig. 3D). Again, target cleaving activity was detected in the
eluate when we used a capture oligo
complementary to seed plus the 3′ sup-
plementary region or to the seed alone,
but not the fully complementary cap-
ture oligo.
Although MEFs express at least three
of the four mammalian Argonaute pro-
teins (Broderick et al. 2011), quantita-
tive mass spectrometry detected in
the eluate only mouse AGO2 (Supple-
mental Table S3), which was 64-fold
enriched over the background control
(Fig. 3C). Perhaps the endogenous
mouse AGO1, AGO3, and AGO4 pro-
teins in the S100 are preoccupied with
endogenous miRNAs and therefore un-
available for loading with exogenous
siRNA.
Separation of a mixture of two RISCs
As a test of specificity, we asked whether
our method can resolve RISCs pro-
grammed with different siRNAs. We
separately assembled let-7 and luciferase
siRNAs into RISC using fly embryo ly-
sate. Next, we mixed the assembly re-
actions and then used a let-7-specific
capture oligo to purify RISC from one-
half of the mixture. We used a lucifer-
ase-specific capture oligo to purify lucif-
erase-siRNA-programmed RISC from
the other half. Finally, we tested the elu-
ates for their ability to cleave either let-7
or luciferase target RNAs. RISC purified
using the let-7-specific capture oligo
only cleaved the let-7 target (Fig. 4).
Conversely, RISC purified using the
luciferase-specific capture oligo only
cleaved the luciferase target. Thus, the
method can separate a mixture of RISCs programmed with
different small RNA sequences.
Efficient purification with good yield
Both fully complementary and partially complementary cap-
ture oligos depleted all (Figs. 2, 3A,B) or most (Fig. 3D)
detectable RISC activity from the lysate, but RISC was re-
covered efficiently only from the partially complementary
capture oligo. To estimate the yield for our purification
method, we measured both the amount of active purified
RISC recovered in the eluate by pre-steady-state kinet-
ic analysis and the differential loss of the passenger and
guide strands (Supplemental Fig. S2A,C,D). Nearly all the
active RISC assembled was recovered from the partially
C Mouse AGO2-RISC
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FIGURE 3. Drosophila Ago1- and Ago2-RISC, as well as mouse AGO2-RISC, can be purified us-
ing a partially complementary capture oligo. (A) A let-7/let-7∗ duplex was loaded into Drosophila
Ago1 or (B) a let-7 siRNA was loaded into Drosophila Ago2 by incubation in Drosophila embryo
lysate and purified with a partially complementary capture oligo. The RISC assembly reaction
(Input), the supernatant after capture (Sup), the first wash, and the eluates were incubated
with 100 nM let-7 complementary target RNA for 10 min (Ago1 and Ago2) and 180 min
(Ago1) at 25°C. (C) Tenfold concentrated, purified Drosophila Ago1- and Ago2-RISC, mouse
AGO2, and control samples were analyzed by quantitative mass spectrometry to determine their
protein composition. The enrichment of each Argonaute protein in the purified RISC was calcu-
lated as the ratio of let-7-programmed, purified samples to control samples in which the small
RNA duplex was omitted (background). (D) let-7-programmed mouse AGO2-RISC was assem-
bled in S100 cytosolic extract from Ago2−/−MEFs overexpressing mouse AGO2, then purified us-
ing either a fully or partially complementary capture oligo. Target cleaving activity was tested
using 100 nM target RNA for 5 min at 37°C.
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complementary capture oligo: 78% for the capture oligo
complementary to the seed plus the 3′ supplementary region
and 80% for the capture oligo complementary to the seed
alone (Table 1). Overall, the specific activity (pmol of active
RISC/milligram of protein) of fly Ago2-RISC increased 790-
fold between the assembly reaction and the eluate of the cap-
ture oligo (Table 2). For mouse AGO2-RISC, the specific ac-
tivity increased 320-fold.
Purification of endogenously
loaded miRNAs
We tested whether our method can also
be used to purify RISC programmed
with endogenous miRNAs. miR-21 is
the most abundant miRNA in MEFs
(JA Broderick and PD Zamore, un-
publ.). We used a capture oligo com-
plementary to the miR-21 seed plus
3′ supplementary region to purify
miR-21-RISC from MEF S100 lysate,
and then tested its ability to cleave a fully complementary
miR-21 target RNA. Active miR-21-programmed RISC was
recovered in the eluate (Fig. 5A).
miR-286 is one of the most abundant miRNAs in 2- to 6-h
Drosophila embryos (Ruby et al. 2007; Chung et al. 2008). We
used a capture oligo complementary to the miR-286 seed
plus 3′ supplementary region to purify miR-286-RISC from
embryo lysate. Northern hybridization demonstrated that
we could successfully recover miR-286 in the eluate of the
capture oligo (Fig. 5B).
Unlike purification of exogenously programmed RISC
from fly embryo or mouse cell lysate, the capture oligo did
not fully deplete the targeted miRNA from the lysate for ei-
ther of the endogenous miRNAs. The failure to deplete
miR-21- or miR-286-RISC from the lysate cannot be ex-
plained by an insufficient amount of capture oligo, because
a second round of incubation with fresh capture oligo failed
to deplete the remaining Drosophila miR-286 (Fig. 5B). The
simplest explanation is that as much as half of the miR-286
in the embryo lysate is bound to its mRNA targets and is
therefore unavailable to bind the capture oligo.
DISCUSSION
We have described a simple method to purify from crude ex-
tracts active RISC complexes containing a single guide RNA
sequence. Our procedure preserves the activity of target-
cleaving Argonaute proteins, but should also find use purify-
ing Argonaute:small RNA complexes that do not catalyze en-
donucleolytic cleavage of their target RNAs.
Our method offers the advantage of purifying freely diffus-
ing RISC complexes that can be used to study small RNA-di-
rected Argonaute enzyme kinetics (Wee et al. 2012). Free
diffusion is essential for quantitative population or single-
molecule analysis of target binding by RISC.
Our method isolates only fully assembled, mature RISC
containing a single-stranded RNA guide (Table 1). Thus,
the proteins that copurify with RISC should be only those
present at the encounter with target. Our mass spectrometry
analyses support this view, because we did not find proteins
that participate in small RNA biogenesis or RISC assembly.
We detected no peptides from Dicer-1, Dicer-2, R2D2,
TABLE 2. Purification of let-7 programmed Ago2-RISC from Drosophila embryo lysate and
AGO2-overexpressing MEF S100
Species
Starting material Final purified RISC
Purification
factor
Total
protein
(mg)
Active
RISC
(pmol)
Specific
activity
(pmol/
mg)
Total
protein
(mg)
Active
RISC
(pmol)
Specific
activity
(pmol/
mg)
Fly 28 12 0.43 0.025 8.6 340 790
Mouse 3.3 2.6 0.78 0.0089 2.3 250 320
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Loquacious, or C3PO (Jiang et al. 2005; Liu et al. 2006, 2007,
2009) copurifying with Drosophila Ago1- or Ago2-RISC, nor
did we detect Dicer, TRBP, or PACT (Hutvágner et al. 2001;
Chendrimada et al. 2005; Haase et al. 2005; Lee et al. 2006)
copurifying with mouse AGO2-RISC (Supplemental Fig.
S3; Supplemental Tables S1–S3).
Heat shock proteins such as Hsp90 and Hsc70 also func-
tion in RISC assembly (Iki et al. 2010; Iwasaki et al. 2010;
Johnston et al. 2010; Miyoshi et al. 2010). Hsc70-4 was en-
riched over background for Drosophila Ago1-RISC purified
by our method (Supplemental Tables S1–S3). Hsc70-4 asso-
ciates with Argonaute during its assembly into RISC, but
Hsc70 and Hsp90 inhibitors had no detectable affect on tar-
get cleavage by Ago2 (Iwasaki et al. 2010); our data suggest
that Hsc70-4 may nonetheless play a role for Ago1 in target
finding, target cleavage, product release, or enzyme regener-
ation after target cleavage. Whereas Ago2 was the most en-
riched protein in the Ago2 sample, other proteins were
highly enriched in the Ago1 sample (Supplemental Table
S1); ribosomal protein L7A was the only protein enriched
in both samples. We do not yet know if these Argonaute-as-
sociated proteins play a role in RISC function.
Although the siRNAs andmiRNAs used here contained no
chemical modifications, we have used the method to purify
RISC programmed with fluorescently labeled siRNA guide
strands (CF Flores-Jasso and PD Zamore, unpubl.). We
envision that our method will prove useful in the biochemi-
cal dissection of the RNAi and miRNA pathways and in
the identification of proteins that modify and extend RISC
function.
MATERIALS AND METHODS
General methods
Synthetic DNA (IDT) and RNA (Dharmacon) oligonucleotides
were gel-purified before use. RNA oligonucleotides were synthesized
containing a 5′ phosphate. The strands of the let-7 and luciferase
siRNA duplexes were annealed in lysis buffer (30 mM HEPES-
KOH at pH 7.4, 100 mM potassium acetate, 2 mM magnesium ac-
etate) using a 1:1.3 molar ratio of guide to passenger. The let-7/let-7∗
duplex was annealed using a 1:5 molar ratio of miRNA to miRNA∗.
Drosophila embryo lysate and MEF S100 cytosolic
extract
Drosophila embryo lysate from 0- to 8-h embryos and RISC assem-
bly were as described (Haley et al. 2003). The protein concentration
of the embryo lysate was ∼30 mg/mL.
S100 extract was generated from SV40 large T-antigen immortal-
ized Ago2−/− MEFs that stably overexpress mouse Ago2 mRNA
(O’Carroll et al. 2007). Cells were grown to confluence in 5%
CO2 at 37°C in DMEM (Invitrogen) supplemented with 15% fetal
bovine serum (PAA Laboratories) and 50 units/mL penicillin and
streptomycin (Invitrogen). S100 extract was prepared as described
(Dignam et al. 1983) except that the cell pellet was washed three
times in ice-cold PBS and once in Buffer A (10 mM HEPES-KOH
at pH 7.9, 10 mM potassium acetate, 1.5 mM magnesium acetate,
0.5 mMDTT, EDTA-free protease inhibitor cocktail). The superna-
tant was removed, and 0.11 cell pellet volumes of Buffer B (300 mM
HEPES-KOH at pH 7.9, 1.4 M potassium acetate, 30 mM magne-
sium acetate, 0.5 mM DTT, EDTA-free protease inhibitor cocktail)
was added, followed by centrifugation at 100,000g for 20 min at 4°C.
Ice-cold 80% (w/v) glycerol was then added to achieve a 13% (w/v)
final glycerol concentration, followed by gentle inversion to mix.
S100 was aliquoted, frozen in liquid nitrogen, and stored at −80°
C. S100 protein concentration was ∼3–4 mg/mL.
Capture oligonucleotides and siRNAs
Streptavidin paramagnetic beads (100 µL; Dynabeads MyOne
Streptavidin T1 10 mg/mL; Invitrogen) were washed and incubated
with 5′ biotinylated, 2′-O-methyl capture oligonucleotides (500
pmol) according to the manufacturer’s instructions, then resus-
pended in 100 µL of lysis buffer containing 2 mM dithiothreitol
(DTT) and kept on ice for RISC purification. The capture oli-
gonucleotides (entirely 2′-O-methyl ribose) were 5′-biotin-
UCUUCACUAUACAACCUACUACCUCAACCUU-3′ (fully com-
plementary to let-7), 5′-biotin-UCUUCCUGCGACAAUAGCC
UACCUCAACCUU-3′ (seed plus 3′ supplementary pairing for let-
7); 5′-biotin-UCUUCCUGCGCACCAAGCCUACCUCAACCUU-
3′ (seed pairing to let-7); 5′-biotin-UCUGACGCACUUGAUUCU
UACGAUUUAUCUA-3′ (seed plus 3′ supplementary pairing for lu-
ciferase siRNA guide); 5′-biotin-GAUGAACCACUCAGAGACA
UAAGCUAAUCUA-3′ (seed plus 3′ supplementary pairing for
mmus-miR-21); 5′-biotin-UCUGACAACGUUGUGUAACCUC
UAGUCCAUCU-3′ (seed plus 3′ supplementary pairing for
Drosophila miR-286). siRNA sequences were 5′-pCGAGGUAGU
AGGUUGUAUAGU-3′ (used as let-7 siRNA guide in Drosophila
embryo lysate) or 5′-pUGAGGUAGUAGGUUGUAUAGU-3′
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FIGURE 5. Purification of endogenous miRNA-RISC complexes. (A)
S100 cytosolic extract from Ago2−/− MEFs overexpressing mouse
AGO2 was concentrated 10-fold and then purified using a capture oligo
partially complementary to mouse miR-21. Target cleavage assays were
performed by incubating samples with 100 nM target RNA for 5 min
(Input, Sup, Eluate) or 30 min (Eluate) at 25°C. (Ø) No incubation.
(B)DrosophilamiR-286 was purified from embryo lysate using a partial-
ly complementary capture oligo. Total RNA from each sample was re-
solved by denaturing electrophoresis and miR-286 was detected by
Northern hybridization.
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(used as let-7 siRNA guide in MEF lysate); 5′-pUAUACAACC
UACUACCUCCUU-3′ (let-7 passenger); 5′-pCAAUCGUAUUU
GUCAAUCAGA-3′ (luciferase guide); 5′-pUGAUUGACAAAUA
CGAUUUUU-3′ (luciferase passenger). miRNA sequences were
5′-pUGAGGUAGUAGGUUGUAUAGU-3′ (let-7); 5′-pUAUACA
AUGUGCUAGCUUUCU-3′ (let-7∗).
RISC purification
The buffer from the washed capture oligo paramagnetic beads (500
pmol of capture oligo on 1 mg of beads) was removed and replaced
with 100 µL of RISC assembly reaction, then incubated with gentle
rotation for 30 min at room temperature. The supernatant was re-
moved, and the beads were washed five times with lysis buffer con-
taining 2 mM DTT and 0.01% (v/v) Triton X-100, followed by five
washes with lysis buffer containing 2M potassium acetate, DTT, and
Triton X-100. RISC was eluted by resuspending the beads in 100 µL
of lysis buffer containing 1M potassium acetate, DTT, Triton X-100,
and 1 nmol (10 µM f.c.) competitor oligo and incubating with gen-
tle rotation for 120 min at room temperature. Competitor sequenc-
es were 5′-AAGGTTGAGGTAGTAGGTTGTATAGTGAAGA-3′
(for the capture oligo fully complementary to let-7); 5′-
AAGGTTGAGGTAGGCTATTGTCGCAGGAAGA-3′ (for the cap-
ture oligo with seed plus 3′ supplementary pairing to let-7); 5′-
AAGGTTGAGGTAGGCTTGGTGCGCAGGAAGA-3′ (for seed
pairing to let-7); 5′-TAGATAAATCGTAAGAATCAAGTGCG
TCAGA-3′ (for seed plus 3′ supplementary to luciferase). 5′-
AGATGGACTAGAGGTTACACAACGTTGTCAGA-3′, (for seed
plus 3′ supplementary pairing to Drosophila miR-286); 5′-
UAGATTAGCUTAUGTCTCTGAGUGGTTCATC-3′, (for seed
plus 3′ supplementary pairing tomousemiR-21). Finally, all samples
were dialyzed at 4°C against three changes (2 h each) of a 2000-fold
excess of lysis buffer containing 2 mMDTT. For quantitative analysis
of yield (Table 1), guide strands were 5′ 32P-radiolabeled.
Ion exchange chromatography on Mono S 5/50 GL (GE
Healthcare) was used to remove competitor DNA. The column
was equilibrated in lysis buffer containing 2 mM DTT. After load-
ing, the column was washed with five column volumes of lysis buffer
containing 2 mMDTT. RISC was eluted with lysis buffer containing
2 mM DTT and 500 mM potassium acetate. The competitor DNA
eluted in the wash. When necessary, samples were concentrated
by centrifugal ultrafiltration (10 kDa cutoff; Amicon).
RISC activity and concentration
Target cleavage assays were as described (Haley et al. 2003). Target
RNAs were transcribed with T7 RNA polymerase from templates
generated by PCR of pGL2 plasmid (Promega) using these primers:
5′-GCGTAATACGACTCACTATAGGGTCACATCTCATCTACCT
CC-3′ (let-7 forward); 5′-CCCATTTAGGTGACACTATAGATTT
ACATCGCGTTGAGTGTAGAACGGTTGTATAAAAGGTTGAGG
TAGTAGGTTGTATAGTATCCAGAGGAATTCATTATCAGTG-3′
(let-7 reverse); 5′-GATGCGTAATACGACTCACTATAGGGT TCC
GCATAGAACTGCCTGCGTCA-3′ (luciferase forward); 5′-TCC
AGATCCACAACCTTCGCTTCA-3′ (luciferase reverse); 5′-GCG
TAATACGACTCACTATAGGGGTCCTTTGATCGTGACAAAAC
AAT-3′ (mouse miR-21 forward); 5′-CCCATTTAGGTGACAC
TATAGATTTACATCTAGTTGAGGTGCGGAACTGTGTATAAAA
GGTTAGCTTATCAGACTGATGTTGAATCCAGAGGAATTCATT
ATCAGTG-3′ (mouse miR-21 reverse). In Supplemental Figure S1,
reaction products were resolved by denaturing polyacrylamide gel
electrophoresis, and the amount of cleaved target was quantified us-
ing an FLA-9000 phosphorimager (GEHealthcare) and ImageGauge
software (Fuji Life Sciences). IC50 values were obtained by fitting
(Igor Pro 6.22, WaveMetrics) the data to the Hill equation assuming
noncooperative behavior. Pre-steady-state kinetic data were fit in
Igor Pro to the burst-and-steady-state equation,
F(t) = E × a
2
(a+ b)2 (1− e
−(a+b)t) + E × ab(a+ b) t
where F(t) is target cleaved with time, E is the enzyme concentration,
and a and b are rate constants according to the following scheme:
E + S −a ES −b E + P.
The concentration of RISC assembled in Drosophila embryo lysate
(Supplemental Fig. S2) was estimated by measuring the loss of 5′
32P-radiolabeled passenger and guide strands. Control reactions, in
which the lysate was pre-incubated with 1 mM (f.c.) N-ethylmalei-
mide (NEM) for 10 min at 4°C to prevent RISC assembly
(Nykanen et al. 2001), demonstrated that differential loss of passen-
ger and guide strands required RISC assembly. Unreacted NEM was
quenched with 1.2 mM (f.c.) DTT. Reaction products were resolved
by denaturing 20% polyacrylamide gel electrophoresis and detected
as described. The rate of siRNA decay was determined separately for
each replicate, and the significance determined using a Student’s
two-sample t-test (GraphPad Prism 5; GraphPad Software).
Northern hybridization
Total RNA (5 µg), isolated from 2- to 6-h fly embryo lysates using
TRIzol (Invitrogen) according to the manufacturer’s instructions,
was resolved on a 0.4-mm thick, 15% denaturing polyacrylamide
sequencing gel. After electrophoresis, the gels were blotted at 20 V
for 1 h to a Hybond-NX membrane (Amersham Biosciences) in
0.5× TBE (Tris-Borate-EDTA) buffer by semidry transfer (Trans-
Blot SD; Bio-Rad). The RNA was cross-linked to the membrane
with freshly prepared 140 mM l-ethyl-3-(3-dimethylaminopropyl)
carbodiimide (Sigma-Aldrich) in 130 mM 1-methylimidazole
(Sigma-Aldrich) (pH 8) for 1 h at 60°C. The DNA oligonucleotide
probe, Drosophila miR-286 5′-AGCACGAGTGTTCGGTCTAG
TCA-3′ (25 pmol), was 5′-radiolabeled with T4 polynucleotide ki-
nase (New England Biolabs) and [γ-32P]ATP (450 μCi per reaction,
specific activity ∼6000 Ci/mmol; PerkinElmer). After labeling, un-
incorporated nucleotides were removed (Sephadex G-25 spin col-
umn; GE Healthcare), and the probes were added to the Church
buffer (Church and Gilbert 1984) and hybridized overnight at 37°
C. Membranes were washed three times for 20 min in 0.01× SSC
containing 0.1% SDS (w/v) at 37°C and exposed to storage phos-
phor screens (Fuji).
Mass spectrometry
For mass spectrometry, RISC was purified from a 2-mL assembly re-
action and then concentrated 10-fold. Proteins were separated from
low-molecular-weight contaminants by a brief period of SDS poly-
acrylamide gel electrophoresis, then a single gel slice containing
all protein was excised, eluted, and digested with trypsin. For
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comparison, control reactions in which the small RNA duplex was
omitted were included (Fig. 3C, background).
Tryptic peptides were dissolved in 0.1% (v/v) trifluoroacetic acid,
loaded onto a fused silica trap column (2 cm × 100 µm C18), and
then fractionated on a fused silica column (25 cm × 75 µm C18) de-
veloped with a linear gradient from 100% solvent A (0.1% formic
acid, 5% acetonitrile in water) to 35% solvent B (0.1% formic
acid in water) at a flow rate of 300 nL/min over 90 min using a
nano LC: EASY system (Proxeon) directly coupled to an LTQ
Orbitrap Velos mass spectrometer (Thermo Scientific). Data-de-
pendent acquisitions from MS scans (350–2000 m/z) in the
Orbitrap at resolution, r = 60,000 were followed by 10 MS/MS scans
acquired in the LTQ ion trap instrument.
Raw data files were processed with Mascot Distiller (Matrix
Science) or Extract-MSn (Thermo Scientific) to generate peak lists
and then searched against the Drosophila melanogaster (NCBInr)
or Mus musculus (UniProtKB/SWISS-PROT) index using Mascot
Search engine 2.3.02 (Matrix Science) with 10 ppm parent mass
and 0.5 Da fragment mass tolerances. Amino acid modifications
considered were acetyl (for the amino terminus of the protein),
pyroglutamic acid (for amino-terminal glutamine), propionamide
and carbamidomethylation modification of cysteine, and oxidation
of methionine. Label-free quantification using extracted ion chro-
matograms (XIC) was performed using both the replicate and aver-
age methods in the Mascot Distiller quantitation software (Matrix
Science). Mascot searches were also loaded into Scaffold3 software
(Proteome Software) for further comparative analyses and filtering.
SUPPLEMENTAL MATERIAL
Supplemental material is available for this article.
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